<DOC>
	<DOCNO>NCT01238588</DOCNO>
	<brief_summary>The hypothesis switch calcium base phosphate binder sevelamer carbonate associate less inflammation include less atherosclerotic plaque inflammation ( inflammation vessel wall ) .</brief_summary>
	<brief_title>The Effect ( ) Sevelamer Carbonate ( Renvela ) Atherosclerotic Plaque Inflammation Judged FDG-PET Scan</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>A signed consent form ; Male Female , 50 year old ; Diagnosed end stage renal disease ( ESRD ) , maintenance hemodialysis least three ( 3 ) month ; On calciumbased phosphate binder ; Subject must able understand provide informed consent ; No known contraindication therapy sevelamer carbonate . Any patient medical condition take medication would contraindicate use sevelamer carbonate , history bowel obstruction ; History severe allergic reaction study medication ; History active infection ( simple respiratory tract infection ) acute gouty attack within 2 week prior enrollment ; Known serological positivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B surface Antigen ( HBsAg ) , Hepatitis C Virus Antibody ( HCV Ab ) except dose normal liver function test ( AST , ALT , Bilirubin , Alkaline Phophatase ) history cirrhosis ; Elevation liver function test time entry ( Aspartate Aminotransferase ( AST ) and/or Alanine Aminotransferase ( ALT ) &gt; 2 time upper limit normal ) ; History drug , alcohol , chemical abuse within 6 month prior enrollment ; History malignancy except adequately treat , complete treatment clinically remission 6 month ; adequately treat insitu cervical carcinoma , adequately treat basal squamous cell carcinoma skin ; History inflammatory disease systemic lupus erythematosus ( SLE ) , rheumatoid arthritis ulcerative colitis except remission 6 month ; Patients currently sevelamer carbonate sevelamer chloride history take week past three month ; Patients receive chronic antiinflammatory therapy ; Patients FDGPET/CT dual scan contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>